Filing Details

Accession Number:
0001209191-23-051766
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-10-03 21:00:19
Reporting Period:
2023-10-02
Accepted Time:
2023-10-03 21:00:19
Original Submission Date:
2023-10-02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899460 Mannkind Corp MNKD Pharmaceutical Preparations (2834) 133607736
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1674282 Michael Castagna 1 Casper Street
Danbury CT 06810
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Disposition 2023-10-02 10,000 $4.08 2,359,147 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022.
  2. Correction of price.